|
UBTD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.001100E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.272400E-02 |
| Normal-vs-Stage2 |
2.071500E-02 |
| Normal-vs-Stage3 |
1.439230E-03 |
| Normal-vs-Stage4 |
1.797910E-04 |
| Stage1-vs-Stage2 |
2.730000E-01 |
| Stage1-vs-Stage3 |
1.009810E-01 |
| Stage1-vs-Stage4 |
2.246300E-02 |
| Stage2-vs-Stage3 |
8.306600E-01 |
| Stage2-vs-Stage4 |
5.395000E-01 |
| Stage3-vs-Stage4 |
6.201800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.843060E-03 |
| Normal-vs-AfricanAmerican |
7.53880000000651E-05 |
| Normal-vs-Asian |
1.629800E-01 |
| Caucasian-vs-AfricanAmerican |
6.360200E-02 |
| Caucasian-vs-Asian |
8.229000E-01 |
| AfricanAmerican-vs-Asian |
5.667600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.355000E-04 |
| Normal-vs-Female |
1.756090E-02 |
| Male-vs-Female |
3.144400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.700400E-02 |
| Normal-vs-Age(41-60Yrs) |
6.278200E-03 |
| Normal-vs-Age(61-80Yrs) |
5.425900E-04 |
| Normal-vs-Age(81-100Yrs) |
5.280300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.131200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.768400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.057800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.746000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.102600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.914400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.643800E-01 |
| Normal-vs-Grade 2 |
1.129800E-01 |
| Normal-vs-Grade 3 |
2.594300E-04 |
| Normal-vs-Grade 4 |
1.11270000002772E-06 |
| Grade 1-vs-Grade 2 |
5.408200E-01 |
| Grade 1-vs-Grade 3 |
1.251970E-01 |
| Grade 1-vs-Grade 4 |
1.493580E-02 |
| Grade 2-vs-Grade 3 |
1.281660E-02 |
| Grade 2-vs-Grade 4 |
1.223160E-04 |
| Grade 3-vs-Grade 4 |
3.002500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.848800E-01 |
| Normal-vs-ccB subtype |
3.164200E-04 |
| ccA subtype-vs-ccB subtype |
1.942540E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.142600E-03 |
| Normal-vs-N1 |
8.034900E-04 |
| N0-vs-N1 |
8.860100E-02 |
|
|
